Trinity Biotech Plc (TRIB)
1.07
-0.07
(-6.14%)
USD |
NASDAQ |
Dec 11, 16:00
1.07
0.00 (0.00%)
After-Hours: 07:31
Trinity Biotech Research and Development Expense (Quarterly): 1.117M for March 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| DBV Technologies SA | 26.82M |
| Cellectis SA | 19.34M |
| Akari Therapeutics Plc | 0.2475M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 2.928M |